Parkinsonas Disease and Nonmotor Dysfunction fills a major gap in the current rapidly growing body of knowledge concerning Parkinsonas disease. Drs. Pfeiffer and Bodis-Wollner have correctly perceived that many nonmotor features of Parkinsonas disease are given insufficient attention in the medical literature. Unfortunately, they are often also given insufficient attention by the practicing neurologists who see these patients. As recently pointed out, there is clearly much more to Parkinsonas disease than depletion of the nigrostriatal dopamine system (1). Parkinsonas disease (not just m- tiple system atrophy) is a multisystem disorder, both pathologically and in its clinical manifestations. This is clearly true for the various motor system abnormalities, which are not fully corrected by dopamine replacement therapy strategies, but also for the nonmotor system abnormalities that are the subject of this volume. Although recently there has been increased awareness of the cognitive, psychiatric, and sleep disorders commonly associated with Parkinsonas disease, many of their manifestations remain under-recognized and their importance in managing patients is underestimated. Even less attention is paid to the myriad of other nonmotor disturbances that plague these patients. For example, among the autonomic disorders, although orthostatic hypotension is well recognized, it is usually attributed to dopaminergic medications rather than to effects of the underlying disease. Urologic disorders are also very familiar in these patients, but may not be properly understood or well managed.This classification system is consistent with DSM IV: Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric ... Singer C, Weiner WJ. ... In: Sexual Dysfunction: a Neuromedical Approach, Futura, Armonk, NY, 1994, pp.
|Title||:||Parkinson's Disease and Nonmotor Dysfunction|
|Author||:||Ronald F. Pfeiffer, Ivan Bodis-Wollner|
|Publisher||:||Springer Science & Business Media - 2007-11-10|